Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 4.830% | 5.592% | -0.156% | 254.305% | 267.172% | 1189.416% | - |
| Cardiff Oncology Inc. | 3.080% | -8.913% | -31.434% | 174.265% | 183.435% | -44.741% | 6.571% |
| Adaptimmune Therapeutics PLC ADR | 4.040% | 17.160% | -26.119% | -21.429% | 58.400% | -74.745% | - |
| X4 Pharmaceuticals, Inc. | -6.150% | -2.304% | -15.185% | -11.923% | 46.795% | - | - |
| Actinium Pharmaceuticals Inc. | 5.460% | -2.309% | -22.830% | -24.259% | 35.730% | -5.615% | - |
| Immuron | 2.780% | -0.917% | -9.244% | 23.429% | 29.341% | -49.296% | - |
| Inotiv Inc. | 1.500% | -9.502% | -60.784% | -14.530% | 21.951% | - | - |
| Indivior plc | -1.210% | -8.840% | -14.685% | -0.483% | 19.392% | 97.605% | 606.638% |
| Dexcom Inc. | -8.730% | 2.045% | -0.402% | 13.909% | 14.987% | 50.134% | 389.506% |
| AstraZeneca plc | 0.210% | 9.087% | 15.435% | 1.341% | 14.444% | 61.006% | 103.448% |
| Fate Therapeutics Inc. | -0.060% | -24.008% | -41.866% | -34.414% | 1.294% | -94.895% | - |
| Stratec SE | 5.380% | 0.251% | -4.762% | -35.380% | -12.854% | -64.476% | -36.204% |
| Esperion Therapeutis.Inc. | -2.240% | 5.592% | -24.315% | 68.534% | -35.523% | -91.873% | -95.201% |
| Abeona Therapeutics Inc. | 6.080% | -58.310% | -57.955% | 5.488% | -37.155% | -91.131% | - |
| Sernova Corp. | -1.100% | -5.505% | -22.599% | -47.090% | -38.047% | -70.346% | - |
| Enlivex Therapeutics Ltd. | 3.080% | -7.143% | -63.068% | -47.154% | -41.964% | -83.951% | - |
| Reata Pharmaceuticals Inc | 1.230% | - | - | - | - | - | - |
| Applied Therapeutics Inc | 2.450% | - | - | - | - | - | - |